Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Dermatitis bullous
ADR ID BADD_A01220
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.01      Bullous conditions
23.03.01.002      Dermatitis bullous
Description Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990) [MeSH]
MedDRA Code 10012441
MeSH ID D012872; D001768
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bulla auricular | Bulla dorsum manus | Bullous dermatitis | Bullous dermatoses | Bullous disorder | Bullous eruption | Bullous lesions | Bullous rash | Bullous rash both arms | Bullous rash upper chest | Dermatitis bullous | Dermatosis bullous | Erythema bullosum | Other specified bullous dermatoses | Rash bullous | Rash vesiculo-bullous | Rash vesiculobullous | Unspecified bullous dermatoses | Vesiculo-bullous eruption | Vesiculo-bullous rash | Vesiculobullous rash | Skin Diseases, Vesiculobullous | Skin Disease, Vesiculobullous | Vesiculobullous Skin Disease | Vesiculobullous Skin Diseases | Vesiculobullous Dermatoses | Dermatoses, Vesiculobullous | Skin Diseases, Bullous | Bullous Skin Disease | Skin Disease, Bullous | Bullous Skin Diseases | Bullous Dermatoses | Dermatoses, Bullous | Vesicular Skin Diseases | Skin Disease, Vesicular | Vesicular Skin Disease | Skin Diseases, Vesicular | Pustular Dermatosis, Subcorneal | Dermatoses, Subcorneal Pustular | Dermatosis, Subcorneal Pustular | Pustular Dermatoses, Subcorneal | Subcorneal Pustular Dermatoses | Sneddon-Wilkinson Disease | Sneddon Wilkinson Disease | Subcorneal Pustular Dermatosis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02029Sitagliptin0.000080%
BADD_D02053Sofosbuvir0.000423%
BADD_D02055Somatropin--
BADD_D02058Sorafenib0.000336%
BADD_D02062Sparfloxacin--
BADD_D02088Sulfacetamide--
BADD_D02093Sulfasalazine0.000455%
BADD_D02098Sumatriptan--
BADD_D02100Sunitinib0.000895%
BADD_D02105Tacrolimus0.001188%
BADD_D02112Tamoxifen citrate--
BADD_D02120Tazarotene--
BADD_D02149Temoporfin--
BADD_D02151Temsirolimus--
BADD_D02154Tenofovir0.004265%
BADD_D02155Tenofovir disoproxil--
BADD_D02160Terbinafine0.000223%
BADD_D02161Terbinafine hydrochloride--
BADD_D02165Teriflunomide0.000603%
BADD_D02170Testosterone--
BADD_D02172Testosterone enanthate--
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
BADD_D02179Tetracycline--
BADD_D02192Thalidomide--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02212Tiaprofenic acid--
BADD_D02217Tigecycline0.000049%
BADD_D02222Tinzaparin sodium--
The 11th Page    First    Pre   11 12 13    Next   Last    Total 13 Pages